Improving outcomes in peripartum cardiomyopathy.
Peripartum cardiomyopathy (PPCM) is a rare condition with a diverse spectrum of potential outcomes, ranging from frequent complete recovery to fulminant heart failure and death. The pathogenesis of PPCM is not well understood, and relatively little is known about its incidence and prevalence. PPCM is often under-recognised in the clinical setting. Early investigation and diagnosis with subsequent expert management may improve outcomes. The development of registries will allow this condition to be better characterised and may help answer crucial questions regarding its optimal medical and surgical management. This paper reviews the potential approaches to improve outcomes in patients with PPCM.
Scottish Advanced Heart Failure Unit, Golden Jubilee National Hospital, Glasgow, G81 4DY, UK.
Jonathan R
JR
Dalzell
Jane A
JA
Cannon
Joanne
J
Simpson
Roy S
RS
Gardner
Mark C
MC
Petrie
D000818:Animals; D009202:Cardiomyopathies / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D058725:Peripartum Period; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D015995:Prevalence; D012042:Registries
heart failure; peripartum cardiomyopathy; pregnancy; prolactin; transplantation; ventricular assist device